Your browser doesn't support javascript.
loading
Pharmacokinetic and Pharmacodynamic Analyses To Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Patients with Serious Infections Caused by Gram-Positive Pathogens.
Lodise, Thomas P; Bosso, John; Kelly, Colleen; Williams, Paul J; Lane, James R; Huang, David B.
Affiliation
  • Lodise TP; Albany College of Pharmacy and Health Sciences, Albany, New York, USA thomas.lodise@acphs.edu.
  • Bosso J; Medical University of South Carolina College of Pharmacy, Charleston, South Carolina, USA.
  • Kelly C; Motif BioSciences, Inc., New York, New York, USA.
  • Williams PJ; Trials by Design, LLC, Stockton, California, USA.
  • Lane JR; Trials by Design, LLC, Stockton, California, USA.
  • Huang DB; Motif BioSciences, Inc., New York, New York, USA.
Article in En | MEDLINE | ID: mdl-29133566

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Pyrimidines / Staphylococcal Skin Infections / Models, Statistical / Gram-Positive Bacterial Infections / Anti-Bacterial Agents Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Language: En Journal: Antimicrob Agents Chemother Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Pyrimidines / Staphylococcal Skin Infections / Models, Statistical / Gram-Positive Bacterial Infections / Anti-Bacterial Agents Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Language: En Journal: Antimicrob Agents Chemother Year: 2018 Document type: Article Affiliation country: Country of publication: